Developing new methods to create and study proteins that interact with cells
High-Throughput Platforms to Study Synthetic Receptors, Natural Molecules, and New Pathway Inhibitors
This study is exploring new ways to create special proteins that can help scientists understand how our bodies work and how to treat diseases better, which could lead to new treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10862880 on NIH RePORTER |
What this research studies
This research focuses on creating advanced platforms that allow scientists to develop and study synthetic receptors and inhibitors in a high-throughput manner. By integrating protein function into the engineering process, the project aims to produce more effective binding proteins and enzymes that can better respond to biological signals. Patients may benefit from the insights gained into how these proteins function in both healthy and diseased states, potentially leading to new therapeutic approaches. The research employs a combination of computational and experimental techniques to enhance the efficiency of protein development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to cell signaling disorders or those who may benefit from novel therapeutic proteins.
Not a fit: Patients with conditions unrelated to protein function or cell signaling may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for various diseases by improving our understanding of protein interactions in cell signaling.
How similar studies have performed: Other research has shown promise in using high-throughput methods for protein engineering, indicating that this approach could yield significant advancements.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Stern, Lawrence a — University of South Florida
- Study coordinator: Stern, Lawrence a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.